| Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report M Brunet, T Van Gelder, A Åsberg, V Haufroid, DA Hesselink, L Langman, ... Therapeutic drug monitoring 41 (3), 261-307, 2019 | 496 | 2019 |
| The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters JM Planas, I Alfaras, H Colom, ME Juan Archives of Biochemistry and Biophysics 527 (2), 67-73, 2012 | 136 | 2012 |
| A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists I Diez, H Colom, J Moreno, R Obach, C Peraire, J Domenech Journal of pharmaceutical sciences 80 (10), 931-934, 1991 | 101 | 1991 |
| A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach F Andreu, H Colom, L Elens, T van Gelder, RHN van Schaik, ... Clinical pharmacokinetics 56, 963-975, 2017 | 88 | 2017 |
| Quality by design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets J Saurí, D Millán, JM Suñé-Negre, H Colom, JR Ticó, M Miñarro, ... International journal of pharmaceutics 477 (1-2), 431-441, 2014 | 75 | 2014 |
| The combination of CYP3A4* 22 and CYP3A5* 3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation N Lloberas, L Elens, I Llaudó, A Padullés, T van Gelder, DA Hesselink, ... Pharmacogenetics and Genomics 27 (9), 313-322, 2017 | 68 | 2017 |
| Do drug transporter (ABCB 1) SNP s and P‐glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic … I Llaudó, H Colom, P Giménez‐Bonafé, J Torras, A Caldés, M Sarrias, ... Transplant International 26 (2), 177-186, 2013 | 60 | 2013 |
| An improved cryopreservation method for porcine buccal mucosa in ex vivo drug permeation studies using Franz diffusion cells S Amores, J Domenech, H Colom, AC Calpena, B Clares, Á Gimeno, ... European Journal of Pharmaceutical Sciences 60, 49-54, 2014 | 58 | 2014 |
| Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients H Colom, N Lloberas, F Andreu, A Caldés, J Torras, F Oppenheimer, ... Kidney international 85 (6), 1434-1443, 2014 | 56 | 2014 |
| Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus A Caldés, H Colom, Y Armendariz, MJ Garrido, IF Troconiz, S Gil-Vernet, ... Antimicrobial agents and chemotherapy 53 (11), 4816-4824, 2009 | 54 | 2009 |
| Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma H Colom, R Farré, D Soy, C Peraire, JM Cendros, N Pardo, M Torrent, ... Therapeutic drug monitoring 31 (1), 76-85, 2009 | 51 | 2009 |
| Population Pharmacokinetic Modeling of trans-Resveratrol and Its Glucuronide and Sulfate Conjugates After Oral and Intravenous Administration in Rats H Colom, I Alfaras, M Maijó, ME Juan, JM Planas Pharmaceutical research 28, 1606-1621, 2011 | 46 | 2011 |
| Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients F Andreu, H Colom, JM Grinyó, J Torras, JM Cruzado, N Lloberas Therapeutic drug monitoring 37 (2), 246-255, 2015 | 42 | 2015 |
| Contribution of population pharmacokinetics to dose optimization of ganciclovir-valganciclovir in solid-organ transplant patients A Padullés, H Colom, O Bestard, E Melilli, N Sabé, R Rigo, J Niubó, ... Antimicrobial agents and chemotherapy 60 (4), 1992-2002, 2016 | 40 | 2016 |
| A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast … M Ruiz-Borrego, B Jimenez, S Antolín, JA García-Saenz, J Corral, Y Jerez, ... Investigational new drugs 37, 98-108, 2019 | 36 | 2019 |
| Determination of ganciclovir in human plasma by ultra performance liquid chromatography–UV detection A Padullés, H Colom, Y Armendariz, G Cerezo, A Caldes, L Pou, J Torras, ... Clinical biochemistry 45 (4-5), 309-314, 2012 | 33 | 2012 |
| Population pharmacokinetics of maslinic acid, a triterpene from olives, after intravenous and oral administration in rats M Sánchez‐González, H Colom, G Lozano‐Mena, ME Juan, JM Planas Molecular nutrition & food research 58 (10), 1970-1979, 2014 | 29 | 2014 |
| Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization LI Soler, A Boix, J Lauroba, H Colom, J Domenech Drug Development and Industrial Pharmacy 38 (10), 1171-1178, 2012 | 28 | 2012 |
| Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics A Caldés, S Gil‐Vernet, Y Armendariz, H Colom, L Pou, J Niubó, L Lladó, ... Transplant Infectious Disease 12 (3), 204-212, 2010 | 28 | 2010 |
| Prediction of free from total mycophenolic acid concentrations in stable renal transplant patients: a population-based approach H Colom, F Andreu, T van Gelder, DA Hesselink, BCM de Winter, ... Clinical pharmacokinetics 57, 877-893, 2018 | 26 | 2018 |
A CALPENAUniversidad de BarcelonaVerified email at ub.edu
